FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Product-specific Guidances for ANDAs

Federal Register notice: FDA updates its listing of product-specific draft and revised draft guidances that provide recommendations on the design of b...

Federal Register

Drug User Fee Reauthorization Meeting

Federal Register notice: FDA announces a 9/28 virtual public meeting entitled Reauthorization of the Prescription Drug User Fee Act.

Medical Devices

Argyle UVC Insertion Tray Class 1 Recall

Cardinal Health recalls its Argyle UVC Insertion Tray because it does not include specific instructions for using the safety scalpel N11 contained in ...

Human Drugs

FDA Outlines New Changes to Drug User Fee Program

FDA posts its Prescription Drug User Fee Act VII commitment letter that describes enhancements to the program that will take place beginning 10/1/2022...

FDA General

Latest Federal Register Notices

FDA Review posts the Federal Register notice for the week ending 8/20/2021.

FDA General

Product Approval Summaries

FDA Review posts product approval summaries for the week ending 8/20/2021.

Federal Register

Ortho-Cept Not Withdrawn Due to Safety/Efficacy: FDA

Federal Register notice: FDA has determined that Janssen Pharmaceuticals Ortho-Cept (desogestrel-ethinyl estradiol) 21- and 28-day oral tablets, 0.15 ...

Medical Devices

FDA Cautions on Robot Surgical Devices for Mastectomies

FDA issues a safety alert reminding patients and health care providers that the safety and effectiveness of robotically-assisted surgical devices for ...

Human Drugs

BMS Opdivo High Risk Urothelial Carcinoma OKd

FDA approves Bristol-Myers Squibbs Opdivo (nivolumab) for the adjuvant treatment of patients with urothelial carcinoma who are at high risk of recurre...

Federal Register

Info Collection on Drug Compounding

Federal Register notice: FDA sends to OMB an information collection revision on human drug compounding, repackaging, and related activities.